159 related articles for article (PubMed ID: 31176734)
1. Long non-coding RNA DILC suppresses bladder cancer cells progression.
Ma QY; Li SY; Li XZ; Zhou TF; Zhao YF; Liu FL; Yu XN; Lin J; Chen FY; Cao J; Xi HJ; Li HY
Gene; 2019 Aug; 710():193-201. PubMed ID: 31176734
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA DILC suppresses cell proliferation and metastasis in colorectal cancer.
Gu LQ; Xing XL; Cai H; Si AF; Hu XR; Ma QY; Zheng ML; Wang RY; Li HY; Zhang XP
Gene; 2018 Aug; 666():18-26. PubMed ID: 29621586
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.
Liang C; Yang P; Han T; Wang RY; Xing XL; Si AF; Ma QY; Chen Z; Li HY; Zhang B
Gene; 2019 Apr; 694():102-110. PubMed ID: 30716440
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA
Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer.
Li QG; Xu XQ; Zhou DY; Jia ZB; Yu BF; Xu FG; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3320-3325. PubMed ID: 31081085
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression.
Zhang H; Wei P; Lv W; Han X; Yang J; Qin S
Cell Biosci; 2019; 9():81. PubMed ID: 31592114
[TBL] [Abstract][Full Text] [Related]
8. Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
Dai R; Zhou Y; Chen Z; Zou Z; Pan Z; Liu P; Gao X
J Cell Biochem; 2020 Oct; 121(10):4214-4225. PubMed ID: 31898364
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lncRNA DILC attenuates neuropathic pain via the SOCS3/JAK2/STAT3 pathway.
Liu Y; Feng L; Ren S; Zhang Y; Xue J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510145
[TBL] [Abstract][Full Text] [Related]
10. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
[TBL] [Abstract][Full Text] [Related]
11. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.
Zhu Z; Xu L; Wan Y; Zhou J; Fu D; Chao H; Bao K; Zeng T
Cancer Biomark; 2018; 22(2):275-281. PubMed ID: 29614625
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA DILC is involved in sepsis by modulating the signaling pathway of the interleukin‑6/signal transducer and activator of transcription 3/Toll‑like receptor 4 axis.
Huang W; Huang L; Wen M; Fang M; Deng Y; Zeng H
Mol Med Rep; 2018 Dec; 18(6):5775-5783. PubMed ID: 30365067
[TBL] [Abstract][Full Text] [Related]
14. The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells.
Yang Z; He L; Lin K; Zhang Y; Deng A; Liang Y; Li C; Wen T
Clin Cancer Res; 2017 Nov; 23(21):6673-6685. PubMed ID: 28765327
[No Abstract] [Full Text] [Related]
15. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.
Yang B; Zhang L; Cao Y; Chen S; Cao J; Wu D; Chen J; Xiong H; Pan Z; Qiu F; Chen J; Ling X; Yan M; Huang S; Zhou S; Li T; Yang L; Huang Y; Lu J
Mol Cancer; 2017 Sep; 16(1):154. PubMed ID: 28946875
[TBL] [Abstract][Full Text] [Related]
17. Exosome-transmitted p120-catenin suppresses hepatocellular carcinoma progression via STAT3 pathways.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Tang X; Guo G; Zhou J; Hüser N
Mol Carcinog; 2019 Aug; 58(8):1389-1399. PubMed ID: 30997702
[TBL] [Abstract][Full Text] [Related]
18. STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.
Bu LL; Zhao ZL; Liu JF; Ma SR; Huang CF; Liu B; Zhang WF; Sun ZJ
Oncotarget; 2015 Dec; 6(39):41944-58. PubMed ID: 26556875
[TBL] [Abstract][Full Text] [Related]
19. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
Seitz AK; Christensen LL; Christensen E; Faarkrog K; Ostenfeld MS; Hedegaard J; Nordentoft I; Nielsen MM; Palmfeldt J; Thomson M; Jensen MT; Nawroth R; Maurer T; Ørntoft TF; Jensen JB; Damgaard CK; Dyrskjøt L
Sci Rep; 2017 Mar; 7(1):395. PubMed ID: 28341852
[TBL] [Abstract][Full Text] [Related]
20. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
